StreetInsider.com News Articles

FDA approves second OTC naloxone nasal spray, Rextovy

Tue, 16 Jun 2026 10:08:22 -0400

The U.S. Food and Drug Administration has approved Rextovy, a 4 milligram naloxone hydrochloride nasal spray, for over-the-counter sale as an emergency treatment for opioid overdose. The approval was granted to Amphastar Pharmaceuticals, Inc.

Consumers may purchase Rextovy without a prescription at pharmacies, convenience stores, and online. The product contains the same active ingredient as other naloxone nasal sprays currently available without a prescription.

The FDA first approved an over-the-counter naloxone nasal spray in 2023. In the 12-month period ending August 2023, 111,451 overdose deaths were reported in the U.S. That figure declined to 68,632 in the 12-month period ending December 2025,

Form 4 Amphastar Pharmaceutical For: Aug 19 Filed by: PRINS RICHARD K

Wed, 03 Jun 2026 21:22:00 -0400

si-local-file:///var/storage/secattach/20260603/26601137.html

Form 4 Amphastar Pharmaceutical For: Aug 19 Filed by: PRINS RICHARD K

Wed, 03 Jun 2026 21:22:00 -0400

si-local-file:///var/storage/secattach/20260603/26601137.html

Form 4 Amphastar Pharmaceutical For: Jun 01 Filed by: Lee Howard

Wed, 03 Jun 2026 21:20:00 -0400

si-local-file:///var/storage/secattach/20260603/26601134.html

Form 4 Amphastar Pharmaceutical For: Jun 01 Filed by: Lee Howard

Wed, 03 Jun 2026 21:20:00 -0400

si-local-file:///var/storage/secattach/20260603/26601134.html

Form 4 Amphastar Pharmaceutical For: Jun 01 Filed by: ZASLOFF MICHAEL A

Wed, 03 Jun 2026 20:34:00 -0400

si-local-file:///var/storage/secattach/20260603/26601064.html

Form 4 Amphastar Pharmaceutical For: Jun 01 Filed by: ZASLOFF MICHAEL A

Wed, 03 Jun 2026 20:34:00 -0400

si-local-file:///var/storage/secattach/20260603/26601064.html

Form 4 Amphastar Pharmaceutical For: Jun 01 Filed by: Gerst Diane G.

Wed, 03 Jun 2026 20:33:00 -0400

si-local-file:///var/storage/secattach/20260603/26601063.html

Form 4 Amphastar Pharmaceutical For: Jun 01 Filed by: Gerst Diane G.

Wed, 03 Jun 2026 20:33:00 -0400

si-local-file:///var/storage/secattach/20260603/26601063.html

Form 4 Amphastar Pharmaceutical For: Jun 01 Filed by: Gaugh David Russell

Wed, 03 Jun 2026 20:31:00 -0400

si-local-file:///var/storage/secattach/20260603/26601056.html

Form 4 Amphastar Pharmaceutical For: Jun 01 Filed by: Gaugh David Russell

Wed, 03 Jun 2026 20:31:00 -0400

si-local-file:///var/storage/secattach/20260603/26601056.html

Form 4 Amphastar Pharmaceutical For: Jun 01 Filed by: Deflin Gayle

Wed, 03 Jun 2026 20:30:00 -0400

si-local-file:///var/storage/secattach/20260603/26601051.html

Form 4 Amphastar Pharmaceutical For: Jun 01 Filed by: Deflin Gayle

Wed, 03 Jun 2026 20:30:00 -0400

si-local-file:///var/storage/secattach/20260603/26601051.html

Form 8-K Amphastar Pharmaceutical For: Jun 01

Wed, 03 Jun 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260603/26599054.html

Form 8-K Amphastar Pharmaceutical For: Jun 01

Wed, 03 Jun 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260603/26599054.html

Amphastar Pharmaceuticals (AMPH) PT Lowered to $20 at Barclays

Wed, 03 Jun 2026 03:45:34 -0400

Barclays analyst Glen Santangelo lowered the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $20.00 (from $23.00) while maintaining a Equalweight rating.

Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference

Wed, 27 May 2026 06:00:00 -0400

RANCHO CUCAMONGA, CA / ACCESS Newswire / May 27, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will be presenting at the 2026 Jefferies Healthcare Conference on Wednesday, June 3, 2026, at 4:55 p.m. ET. For access to the webcast, visit Amphastar Pharmaceuticals' website at http://ir.amphastar.com. This webcast will be available for 30 days following the presentation.

About Amphastar Pharmaceuticals, Inc.

Amphastar is a biopharmaceutical company that focuses on developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and

Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference

Wed, 27 May 2026 06:00:00 -0400

About Amphastar Pharmaceuticals, Inc.

Amphastar is a biopharmaceutical company that focuses on developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and

Wells Fargo Downgrades Amphastar Pharmaceuticals (AMPH) to Equal Weight

Thu, 14 May 2026 05:16:14 -0400

Wells Fargo analyst Benjamin Burnett downgraded Amphastar Pharmaceuticals (NASDAQ: AMPH) from Overweight to Equal Weight with a price target of $19.00.

For an analyst ratings summary and ratings history on Amphastar Pharmaceuticals click here. For more ratings news on Amphastar Pharmaceuticals click here.

Shares of Amphastar Pharmaceuticals closed at $18.32 yesterday.

Amphastar Pharmaceuticals (AMPH) PT Lowered to $21 at Piper Sandler

Mon, 11 May 2026 06:46:43 -0400

Piper Sandler analyst David Amsellem lowered the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $21.00 (from $25.00) while maintaining a Neutral rating.

Needham Downgrades Amphastar Pharmaceuticals (AMPH) to Hold

Fri, 08 May 2026 07:10:30 -0400

Needham analyst Serge Belanger downgraded Amphastar Pharmaceuticals (NASDAQ: AMPH) from Buy to Hold.

For an analyst ratings summary and ratings history on Amphastar Pharmaceuticals click here. For more ratings news on Amphastar Pharmaceuticals click here.

Shares of Amphastar Pharmaceuticals closed at $24.03 yesterday.

Amphastar Pharma (AMPH) Misses Q1 EPS by 30c

Fri, 08 May 2026 01:01:47 -0400

Amphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of $0.42, $0.30 worse than the analyst estimate of $0.72. Revenue for the quarter came in at $171.2 million versus the consensus estimate of $176.32 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

Form 10-Q Amphastar Pharmaceutical For: Mar 31

Thu, 07 May 2026 16:49:00 -0400

si-local-file:///var/storage/secattach/20260507/26454752.html

Form 10-Q Amphastar Pharmaceutical For: Mar 31

Thu, 07 May 2026 16:49:00 -0400

si-local-file:///var/storage/secattach/20260507/26454752.html

Form 8-K Amphastar Pharmaceutical For: May 07

Thu, 07 May 2026 16:23:00 -0400

si-local-file:///var/storage/secattach/20260507/26454004.html